Header Logo

Connection

ADAM VOGEL to Receptor, Fibroblast Growth Factor, Type 2

Back to Details
This is a "connection" page, showing publications ADAM VOGEL has written about Receptor, Fibroblast Growth Factor, Type 2.
ADAM VOGEL
Connection Strength
0.220
Receptor, Fibroblast Growth Factor, Type 2
  1. An open-label study of pemigatinib in cholangiocarcinoma: final results from FIGHT-202. ESMO Open. 2024 Jun; 9(6):103488.
    View in: PubMed
    Score: 0.220
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.